BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yasmin F, Najeeb H, Naeem A, Dapke K, Phadke R, Asghar MS, Shah SMI, De Berardis D, Ullah I. COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management. Diseases 2021;9:65. [PMID: 34698143 DOI: 10.3390/diseases9040065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Dwivedi S, Choudhary P, Gupta A, Singh S. The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19. Crit Rev Microbiol 2022;:1-16. [PMID: 35324372 DOI: 10.1080/1040841X.2022.2052795] [Reference Citation Analysis]
2 Bilgic A, Kodjikian L, Sudhalkar A, Dwivedi S, Vasavada V, Shah A, Dziadzko M, Mathis T. Risk Factors for COVID-19 Associated Mucormycosis: The Ophthalmologist’s Perspective. JoF 2022;8:271. [DOI: 10.3390/jof8030271] [Reference Citation Analysis]
3 Mirchin R, Czeresnia JM, Orner EP, Chaturvedi S, Murphy K, Nosanchuk JD. The Continuing Emergence of Candida blankii as a Pathogenic Fungus: A New Case of Fungemia in a Patient Infected with SARS-CoV-2. JoF 2022;8:166. [DOI: 10.3390/jof8020166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Moorthy A, Nayak T, Bachalli PS, Tripathi KK, Dutt SN, Kale P, Bhat P, Suresh PK, Gaikwad R, Raju A, Krishna S, Conjeevaram A, Mehta S, Anil-Kumar A, Haldipur D. COVID-associated rhinocerebral mucormycosis: a retrospective analysis of presentation and outcomes. Eur Arch Otorhinolaryngol 2022. [PMID: 35849188 DOI: 10.1007/s00405-022-07544-y] [Reference Citation Analysis]
5 Naveen KV, Saravanakumar K, Sathiyaseelan A, Mubarakali D, Wang M. Human Fungal Infection, Immune Response, and Clinical Challenge—a Perspective During COVID-19 Pandemic. Appl Biochem Biotechnol. [DOI: 10.1007/s12010-022-03979-5] [Reference Citation Analysis]
6 Samson R, Dharne M. COVID-19 associated mucormycosis: evolving technologies for early and rapid diagnosis. 3 Biotech 2022;12:6. [PMID: 34900512 DOI: 10.1007/s13205-021-03080-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Saied AA, Metwally AA, Dhama K. Our children are at risk of COVID-19- associated rhino-orbito-cerebral mucormycosis (ROCM). Ann Med Surg (Lond) 2021;72:103058. [PMID: 34804523 DOI: 10.1016/j.amsu.2021.103058] [Reference Citation Analysis]
8 Janjua OS, Shaikh MS, Fareed MA, Qureshi SM, Khan MI, Hashem D, Zafar MS. Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes. J Fungi (Basel) 2021;8:44. [PMID: 35049983 DOI: 10.3390/jof8010044] [Reference Citation Analysis]
9 Krishna V, Bansal N, Morjaria J, Kaul S. COVID-19-Associated Pulmonary Mucormycosis. JoF 2022;8:711. [DOI: 10.3390/jof8070711] [Reference Citation Analysis]